Cargando…

Therapeutic Vaccines for HPV-Associated Malignancies

Human papillomavirus (HPV)-related malignancies are responsible for almost all cases of cervical cancer in women, and over 50% of all cases of head and neck carcinoma. Worldwide, HPV-positive malignancies account for 4.5% of the global cancer burden, or over 600,000 cases per year. HPV infection is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smalley Rumfield, Claire, Roller, Nicholas, Pellom, Samuel Troy, Schlom, Jeffrey, Jochems, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549137/ https://www.ncbi.nlm.nih.gov/pubmed/33117742 http://dx.doi.org/10.2147/ITT.S273327

Ejemplares similares

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
por: Smalley Rumfield, Claire, et al.
Publicado: (2020)

Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009
por: Pellom, Samuel T., et al.
Publicado: (2021)

Combination Therapies for HPV-Associated Malignancies
por: Smalley Rumfiled, Claire, et al.
Publicado: (2020)

The Use of a Humanized NSG-β2m(−/−) Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa
por: Morillon, Y. Maurice, et al.
Publicado: (2020)

The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex
por: Jochems, Caroline, et al.
Publicado: (2018)

Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824)
por: Jochems, Caroline, et al.
Publicado: (2017)

Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa
por: Tsai, Yo-Ting, et al.
Publicado: (2022)

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
por: Lee, Maxwell Y., et al.
Publicado: (2021)

Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer
por: Tucker, Jo A., et al.
Publicado: (2012)

Perspectives for therapeutic HPV vaccine development
por: Yang, Andrew, et al.
Publicado: (2016)

Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials
por: Tang, Jianming, et al.
Publicado: (2022)

The role of soluble CD40L in immunosuppression
por: Schlom, Jeffrey, et al.
Publicado: (2013)

Novel Antigenic Targets of HPV Therapeutic Vaccines
por: Boilesen, Ditte Rahbæk, et al.
Publicado: (2021)

The Consequence of Immune Suppressive Cells in the Use of Therapeutic Cancer Vaccines and Their Importance in Immune Monitoring
por: Vergati, Matteo, et al.
Publicado: (2011)

The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19
por: Schlom, Jeffrey, et al.
Publicado: (2020)

Therapeutic Vaccination for HPV Induced Cervical Cancers
por: Brinkman, Joeli A., et al.
Publicado: (2007)

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
por: Lind, Hanne, et al.
Publicado: (2020)

Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
por: Morgan, Ethan L., et al.
Publicado: (2020)

Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine
por: Farsaci, Benedetto, et al.
Publicado: (2013)

Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
por: Morand, Grégoire B., et al.
Publicado: (2022)

Therapeutic vaccines for high-risk HPV-associated diseases
por: Chabeda, Aleyo, et al.
Publicado: (2017)

Effects of conventional therapeutic interventions on the number and function of regulatory T cells
por: Roselli, Mario, et al.
Publicado: (2013)

Therapeutic Vaccines for Genitourinary Malignancies
por: Dutcher, Giselle M. A., et al.
Publicado: (2018)

Therapeutic Vaccination for HPV-Mediated Cancers
por: Yan, Flora, et al.
Publicado: (2023)

New Perspectives in Therapeutic Vaccines for HPV: A Critical Review
por: Gardella, Barbara, et al.
Publicado: (2022)

Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
por: Di Bonito, Paola, et al.
Publicado: (2019)

Vaccines against Human Carcinomas: Strategies to Improve Antitumor Immune Responses
por: Palena, Claudia, et al.
Publicado: (2010)

Updates on HPV Vaccination
por: Illah, Ojone, et al.
Publicado: (2023)

Therapeutic vaccines for malignant brain tumors
por: Gustafson, Michael P, et al.
Publicado: (2008)

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
por: Peng, Shiwen, et al.
Publicado: (2014)

Combination therapies utilizing neoepitope-targeted vaccines
por: Lee, Karin L., et al.
Publicado: (2020)

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
por: Osaghae, Ikponmwosa, et al.
Publicado: (2022)

Malignancy Associated with Low-Risk HPV6 and HPV11: A Systematic Review and Implications for Cancer Prevention
por: da Silva, Leandro Lima, et al.
Publicado: (2023)

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
por: Jochems, Caroline, et al.
Publicado: (2013)

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)
por: Boyerinas, Benjamin, et al.
Publicado: (2013)

Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis
por: Okoye, Jude Ogechukwu, et al.
Publicado: (2021)

Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination
por: Suppli, Camilla Hiul, et al.
Publicado: (2018)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies
por: Lui, Grace, et al.
Publicado: (2023)

Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis
por: Gilbert, Duncan C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vsddi2mcsam2jp84qhuaip0l50